Cytochroma Limited
Cytochroma Limited develops human iPSC cell models to predict clinical outcomes, offering protocols and models for consistent results. Their approach focuses on understanding drug reactions during the development process.
- Advanced iPSC models
- Contract Research Services
- Drug-induced Liver Injury prediction
- Disease models for target validation
- Custom differentiation of iPS differentiated cells